I have to run the numbers again @madamswer. Before the recent turn of events (poor FY18 numbers and executive churn), I would have been happy to pay up the current multiples, even after the huge recovery today. It would be great to get your updated take on the situation.
Your arguments are unimpeachable of course. Getting back into the black is just a fortunate consequence of having a reasonable entry price and holding on through the recent troubles that beset the company, though admittedly my conviction was weak.
While not completely out of the water by any stretch, today's update reaffirms the fundamentals and growth outlook for the company and casts the recent struggles as a "one-off" event of sorts, so I am inclined to continue holding the majority of my position. I may trim it a little more in subsequent weeks to free up some cash and get the company's weighting to a more palatable level. It is currently just under 4% of my portfolio. It is hardly fathomable that it was once close to my largest holding during the run up beyond $4!
- Forums
- ASX - By Stock
- It's a buy. Pure and Simple.
I have to run the numbers again @madamswer. Before the recent...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IRI (ASX) to my watchlist
(20min delay)
|
|||||
Last
59.0¢ |
Change
0.005(0.85%) |
Mkt cap ! $104.7M |
Open | High | Low | Value | Volume |
61.0¢ | 61.0¢ | 58.5¢ | $73.86K | 122.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14074 | 59.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.5¢ | 2453 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2575 | 2.440 |
2 | 897 | 2.430 |
2 | 7887 | 2.420 |
2 | 2724 | 2.410 |
2 | 8724 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.450 | 5861 | 2 |
2.460 | 17285 | 6 |
2.470 | 724 | 1 |
2.480 | 22461 | 5 |
2.490 | 17590 | 5 |
Last trade - 11.15am 25/11/2024 (20 minute delay) ? |
Featured News
IRI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online